Skip to content

Fluid Management for Cesarean Section

Fluid Management With Ringer's and 6% Starch for Cesarean Section After Epidural or Spinal Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00488111
Acronym
FMCS
Enrollment
850
Registered
2007-06-19
Start date
2007-05-31
Completion date
2008-08-31
Last updated
2008-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section

Keywords

Regional anesthesia, Fluid Therapy, Hemostasis, Surgical

Brief summary

Cesarean section-associated hypotension is one of the pivotal factors to influence the Apgar Score of children and related with the stable hemostasis during the whole process of labor. How to keep circulation in a consistent stability is yet to be known. The investigators hypothesized that different fluids, crystalloids or colloids, can produced varying effects in keeping the physiological environment of labor from significant fluctuating.

Interventions

OTHERRinger's Lactate

Ringer's Lactate was used 15min before operation

OTHER6% Starch

6% Starch was used 15min before operation

Sponsors

HRSA/Maternal and Child Health Bureau
CollaboratorFED
Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* 21-40 yr * First time of delivery * ASA status I-II * No premature * No genetic and infectious diseases * Chinese

Exclusion criteria

* \< 21 yr * \> 40 yr * Subjects with cardiac and pulmonary disorders * Dislocation of placenta * Pregnant hypertension * Allergy to local anesthetics * Unwilling to cooperation * Need intraoperative administration of vascular active agents * With significant delivery side effects

Design outcomes

Primary

MeasureTime frame
Total volume of colloid Total volume of crystalloid Total fluid volume6 months

Secondary

MeasureTime frame
Percentage reduction in hematocrit, Days in hospital6 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026